The most recent short interest data has been released for the 05/31/2017 settlement date, which shows a 874,390 share decrease in total short interest for McKesson Corp ( MCK), to 3,950,969, a decrease of 18.12% since 05/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days (at the average volume) it would take to close out all of the open short positions if every share traded represented a short position being closed. Average daily volume for MCK at the 05/31/2017 settlement increased to 2,602,680, as compared to 1,350,766 at the 05/15/2017 report. That brought "days to cover" down to 1.52, a 57.51% decrease from the 3.57 days to cover calculated at the previous short interest data release.

The below chart shows the historical "days to cover" for MCK at previous short interest release dates:

START SLIDESHOW:
Top 25 S.A.F.E. Dividend Stocks »

Loading+chart++2017+TickerTech.com

A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could also indicate a long bet elsewhere was closed where MCK had been shorted as a hedge.

The chart below shows the one year performance of MCK shares, versus its 200 day moving average. Looking at this chart, MCK's low point in its 52 week range is $114.53 per share, with $199.43 as the 52 week high point — that compares with a last trade of $162.04.

McKesson Corp Chart

According to the ETF Finder at ETF Channel, MCK makes up 4.76% of the Pharmaceutical ETF (PPH) which is lower by about 0.4% on the day Monday.

If you liked this article you might like

How World's Largest Drug Distributor Is Helping Harvey Victims Treat Snakebites

J&J Enters Death Penalty Debate, Protests Use of Drug in Lethal Injection

Eclipse in the USA: Then and Now

Finding Value in a Pricey Environment

Allscripts Stock Climbs, Cantor Upgrades After McKesson Deal